MEMBRANE DYNAMICS AND FUNCTIONAL EFFECTS ON MYELOMA CELLS AFTER DARATUMUMAB TREATMENT

被引：0
作者：
Yakymiv, Y. [1 ]
Faini, A. C. [1 ]
Castella, B. [1 ]
Morandi, F. [1 ]
Larocca, A. [1 ]
Oliva, S. [1 ]
Horenstein, A. L. [1 ]
Massaia, M. [1 ]
Malavasi, F. [1 ]
机构：
[1] Dipartimento Sci Med, Lab Immunogenet, Turin, Italy
来源：
HAEMATOLOGICA | 2018年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
CO095
引用
收藏
页码：S66 / S66
页数：1
相关论文
共 50 条
  • [31] Early leukoencephalopathy during daratumumab treatment in a patient with multiple myeloma
    Liu, Shanshan
    Zhou, Hongwei
    Xu, Weiling
    Jin, Tao
    Liang, Xinyue
    Zhao, Xiaoxia
    Dai, Yun
    Jin, Fengyan
    [J]. ANNALS OF HEMATOLOGY, 2023, 102 (04) : 967 - 969
  • [32] Daratumumab and its use in the treatment of relapsed and/or refractory multiple myeloma
    Chehab, Sarah
    Panjic, Elyse Hall
    Gleason, Charise
    Lonial, Sagar
    Nooka, Ajay K.
    [J]. FUTURE ONCOLOGY, 2018, 14 (30) : 3111 - 3121
  • [33] Treatment with Daratumumab in Patients with Multiple Myeloma Associated AL Amyloidosis
    Milani, Paolo
    Fazio, Francesca
    Basset, Marco
    Berno, Tamara
    Larocca, Alessandra
    Foli, Andrea
    Riva, Marcello
    Oliva, Stefania
    Ripepi, Jessica
    Nuvolone, Mario
    Petrucci, Maria Teresa
    Merlini, Giampaolo
    Palladini, Giovanni
    [J]. BLOOD, 2019, 134
  • [34] EMA Review of Daratumumab for the Treatment of Adult Patients with Multiple Myeloma
    Tzogani, Kyriaki
    Penninga, Elisabeth
    Christiansen, Marie Louise Schougaard
    Hovgaard, Doris
    Sarac, Sinan B.
    Jimenez, Jorge Camarero
    Garcia, Isabel
    Lafuente, Marta
    Sancho-Lopez, Arantxa
    Salmonson, Tomas
    Gisselbrecht, Christian
    Pignatti, Francesco
    [J]. ONCOLOGIST, 2018, 23 (05) : 594 - 602
  • [35] Efficacy and safety of daratumumab in the treatment of relapsed/refractory multiple myeloma
    Chen, Pingping
    Ma, Jiexian
    Qian, Wensi
    Wu, Min
    Shen, Lin
    Xie, Yanhui
    [J]. MINERVA PEDIATRICS, 2024, 76 (01): : 121 - 123
  • [36] Real-world clinical outcomes in patients with multiple myeloma treated with isatuximab after daratumumab treatment
    Taku Kikuchi
    Nobuhiro Tsukada
    Moe Nomura
    Yuki Kasuya
    Yuki Oda
    Kota Sato
    Tomomi Takei
    Mizuki Ogura
    Yu Abe
    Kenshi Suzuki
    Tadao Ishida
    [J]. Annals of Hematology, 2023, 102 : 1477 - 1483
  • [37] Real-world clinical outcomes in patients with multiple myeloma treated with isatuximab after daratumumab treatment
    Kikuchi, Taku
    Tsukada, Nobuhiro
    Nomura, Moe
    Kasuya, Yuki
    Oda, Yuki
    Sato, Kota
    Takei, Tomomi
    Ogura, Mizuki
    Abe, Yu
    Suzuki, Kenshi
    Ishida, Tadao
    [J]. ANNALS OF HEMATOLOGY, 2023, 102 (06) : 1477 - 1483
  • [38] MODULATION OF THE IMMUNE MICROENVIROMENT IN MULTIPLE MYELOMA PATIENTS TREATED WITH DARATUMUMAB-BASED THERAPY: TUMOR CELL-EXTRINSIC EFFECTS OF DARATUMUMAB TREATMENT
    Castella, B.
    D'Agostino, M.
    Giannotta, C.
    Oliva, S.
    Genuardi, E.
    Gilestro, M.
    Ruggeri, M.
    Corradini, P.
    Ziccheddu, B.
    Maura, F.
    Blasi, S.
    Bolli, N.
    Larocca, A.
    Boccadoro, M.
    Massaia, M.
    [J]. HAEMATOLOGICA, 2020, 105 : S35 - S35
  • [39] Immunomodulatory Effects and Adaptive Immune Response to Daratumumab in Multiple Myeloma
    Krejcik, Jakub
    Casneuf, Tineke
    Nijhof, Inger
    Verbist, Bie
    Bald, Jaime
    Plesner, Torben
    Liu, Kevin
    van de Donk, Niels W. C. J.
    Weiss, Brendan
    Ahmadi, Tahamtan
    Lokhorst, Henk M.
    Mutis, Tuna
    Sasser, A. Kate
    [J]. BLOOD, 2015, 126 (23)
  • [40] Membrane Protein Dynamics and Functional Implications in Mammalian Cells
    Alenghat, Francis J.
    Golan, David E.
    [J]. FUNCTIONAL ORGANIZATION OF VERTEBRATE PLASMA MEMBRANE, 2013, 72 : 89 - 120
12345